Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT02037269
Eligibility Criteria:
Inclusion Criteria
* Females ≥30 years of age with a diagnosis of invasive breast cancer or DCIS
* Scheduled for BCS +/- SLNB or ALND
* Females of childbearing age must have a negative pregnancy test (by Beta HCG qualitative analysis), must have had a history of a surgical sterilisation, or must give history of no menses in past twelve months
Exclusion Criteria
* Surgery or radiotherapy in the operated breast in the past 2 years
* Neoadjuvant systemic therapy
* Patients not suitable for BCS
* Blood glucose level ≥ 12 mmol/l on the day of surgery
* Known hypersensitivity to 18F-FDG
* Any patient who is pregnant or lactating
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
30 Years
Study:
NCT02037269
Study Brief:
Protocol Section:
NCT02037269